Abstract:Metastatic potential of basal-like breast cancers typically is initiated by genetic alterations that lead to a process known as epithelial-mesenchymal transition (EMT). However, much is currently not understood regarding the role of epigenetic modifications that lead to invasive characteristics and EMT phenotype of metastatic breast cancers. Based on the previous notion connecting epigenetic changes to breast cancer metastasis, we performed DIA-based mass spectrometry of isolated histones from an isogenic panel of MCF10A breast cell lines where the tumor suppressor genes TP53 and PTEN were silenced and induced EMT. With this approach, we determined which histone modifications were differentially enriched in the non-EMT and EMT-induced MCF10A cell lines. From approximately 72 histone modifications identified and annotated from our mass spectrometry results, we were able to identify 5 histone events that were differentially enriched in our MCF10A cell line panel. Two events of note were histone H3 lysine-14 acetylation (H3K14ac) significantly increasing and histone H4 arginine 55 dimethylation (H4R55me2) significantly decreasing in our EMT-transformed MCF10A p53-/PTEN- cell lines when compared to the parental, non-tumorigenic MCF10A cell line, showing these events are differentially affected during the EMT process in breast cancer cells. Furthermore, significant arginine demethylation of H4R55me2 & H3.1R83me in the EMT-transformed MCF10A p53-/PTEN- cell lines corresponded with JMJD6, an established histone arginine demethylase, being overexpressed in basal-like breast cancer cell lines as well as basal-like breast cancer patients from The Cancer Genome Atlas (TCGA) and METABRIC datasets. Based on histone proteomic profiling of our isogenic cell line model, the loss of specific histone arginine methylation events corresponding with JMJD6 overexpression could highlight the potential for a targetable epigenetic mechanism in breast cancer metastasis. Citation Format: Charlotte B. McGuinness, Megan A. Wilson, Margaret V. Leonard, Maria Ouzounova, Hasan Korkaya, Austin Y. Shull. Histone proteomic profiling of EMT-transformed MCF10A breast cells demonstrates a loss in novel histone arginine methylation sites via dual p53 and PTEN deletion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1740.

Epigenomic Analysis in a Cell-Based Model Reveals the Roles of H3K9me3 in Breast Cancer Transformation

Global Histone Modification Profiling Reveals the Epigenomic Dynamics During Malignant Transformation in a Four-Stage Breast Cancer Model

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

The Risk Model Construction of the Genes Regulated by H3K36me3 and H3K79me2 in Breast Cancer.

The Hyper-Activation of Transcriptional Enhancers in Breast Cancer.

Genome-wide Analysis of H3K36me3 and Its Regulations to Cancer-Related Genes Expression in Human Cell Lines

Loss of Snail Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Epigenetic Plasticity of Enhancers in Cancer

H3K36 trimethylation-mediated biological functions in cancer

Global DNA Hypomethylation Coupled to Repressive Chromatin Domain Formation and Gene Silencing in Breast Cancer.

Direct ChIP-bisulfite Sequencing Reveals a Role of H3K27me3 Mediating Aberrant Hypermethylation of Promoter CpG Islands in Cancer Cells.

DNA methylation profiles capturing breast cancer heterogeneity

Effect of the Key Histone Modifications on the Expression of Genes Related to Breast Cancer.

Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer

Epigenetic contribution to cancer

Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29

Systematical Identification of Cell-Specificity of CTCF-gene Binding Based on Epigenetic Modifications.

Unveiling epigenetic regulatory elements associated with breast cancer development

Genomes and epigenomes of matched normal and tumor breast tissue reveal diverse evolutionary trajectories and tumor-host interactions

Abstract 1740: Histone proteomic profiling of EMT-transformed MCF10A breast cells demonstrates a loss in novel histone arginine methylation sites via dual p53 and PTEN deletion